Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severeCOVID-19infection in a multi-siteUKacute hospital trust

Daniel M. Bean; Zeljko Kraljevic; Thomas Searle; Rebecca Bendayan; O'Gallagher Kevin; Andrew Pickles; Amos Folarin; Lukasz Roguski; Kawsar Noor; Anthony Shek; Rosita Zakeri; Ajay M. Shah; James T. H. Teo; Richard J. B. Dobson

doi:10.1002/ejhf.1924

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severeCOVID-19infection in a multi-siteUKacute hospital trust

Daniel M. Bean, Zeljko Kraljevic, Thomas Searle, Rebecca Bendayan, O'Gallagher Kevin, Andrew Pickles, Amos Folarin, Lukasz Roguski, Kawsar Noor, Anthony Shek, Rosita Zakeri, Ajay M. Shah, James T. H. Teo, Richard J. B. Dobson

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	967-974
Journal	EUROPEAN JOURNAL OF HEART FAILURE
Volume	22
Issue number	6
DOIs	https://doi.org/10.1002/ejhf.1924
Publication status	Published - Jun 2020

Keywords

COVID-19
Angiotensin-converting enzyme inhibitors
Hypertension
Disease outcome

Access to Document

10.1002/ejhf.1924

Cite this

Bean, D. M., Kraljevic, Z., Searle, T., Bendayan, R., Kevin, OG., Pickles, A., Folarin, A., Roguski, L., Noor, K., Shek, A., Zakeri, R., Shah, A. M., Teo, J. T. H., & Dobson, R. J. B. (2020). Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severeCOVID-19infection in a multi-siteUKacute hospital trust. EUROPEAN JOURNAL OF HEART FAILURE, 22(6), 967-974. https://doi.org/10.1002/ejhf.1924

@article{c16a6c6e293a4b19b90f738e9c16509f,

title = "Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severeCOVID-19infection in a multi-siteUKacute hospital trust",

keywords = "COVID-19, Angiotensin-converting enzyme inhibitors, Hypertension, Disease outcome",

author = "Bean, {Daniel M.} and Zeljko Kraljevic and Thomas Searle and Rebecca Bendayan and O'Gallagher Kevin and Andrew Pickles and Amos Folarin and Lukasz Roguski and Kawsar Noor and Anthony Shek and Rosita Zakeri and Shah, {Ajay M.} and Teo, {James T. H.} and Dobson, {Richard J. B.}",

year = "2020",

month = jun,

doi = "10.1002/ejhf.1924",

language = "English",

volume = "22",

pages = "967--974",

journal = "EUROPEAN JOURNAL OF HEART FAILURE",

issn = "1388-9842",

publisher = "John Wiley & Sons, Ltd",

number = "6",

}

Bean, DM , Kraljevic, Z , Searle, T , Bendayan, R, Kevin, OG, Pickles, A , Folarin, A, Roguski, L, Noor, K, Shek, A , Zakeri, R , Shah, AM , Teo, JTH & Dobson, RJB 2020, 'Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severeCOVID-19infection in a multi-siteUKacute hospital trust', EUROPEAN JOURNAL OF HEART FAILURE, vol. 22, no. 6, pp. 967-974. https://doi.org/10.1002/ejhf.1924

TY - JOUR

T1 - Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severeCOVID-19infection in a multi-siteUKacute hospital trust

AU - Bean, Daniel M.

AU - Kraljevic, Zeljko

AU - Searle, Thomas

AU - Bendayan, Rebecca

AU - Kevin, O'Gallagher

AU - Pickles, Andrew

AU - Folarin, Amos

AU - Roguski, Lukasz

AU - Noor, Kawsar

AU - Shek, Anthony

AU - Zakeri, Rosita

AU - Shah, Ajay M.

AU - Teo, James T. H.

AU - Dobson, Richard J. B.

PY - 2020/6

Y1 - 2020/6

KW - COVID-19

KW - Angiotensin-converting enzyme inhibitors

KW - Hypertension

KW - Disease outcome

U2 - 10.1002/ejhf.1924

DO - 10.1002/ejhf.1924

M3 - Article

SN - 1388-9842

VL - 22

SP - 967

EP - 974

JO - EUROPEAN JOURNAL OF HEART FAILURE

JF - EUROPEAN JOURNAL OF HEART FAILURE

IS - 6

ER -